These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
594 related items for PubMed ID: 18571668
1. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus. Yoshikawa T, Sugita T, Mukai Y, Yamanada N, Nagano K, Nabeshi H, Yoshioka Y, Nakagawa S, Abe Y, Kamada H, Tsunoda S, Tsutsumi Y. J Mol Biol; 2008 Jul 25; 380(5):777-82. PubMed ID: 18571668 [Abstract] [Full Text] [Related]
2. Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo. Kim D, Jeon C, Kim JH, Kim MS, Yoon CH, Choi IS, Kim SH, Bae YS. Exp Cell Res; 2006 May 01; 312(8):1277-88. PubMed ID: 16466653 [Abstract] [Full Text] [Related]
3. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Albarran B, To R, Stayton PS. Protein Eng Des Sel; 2005 Mar 01; 18(3):147-52. PubMed ID: 15820981 [Abstract] [Full Text] [Related]
4. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains. Yoshikawa T, Sugita T, Mukai Y, Abe Y, Nakagawa S, Kamada H, Tsunoda S, Tsutsumi Y. Biomaterials; 2009 Jul 01; 30(19):3318-23. PubMed ID: 19304319 [Abstract] [Full Text] [Related]
5. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5. Goda N, Tenno T, Inomata K, Shirakawa M, Tanaka T, Hiroaki H. Exp Cell Res; 2008 Aug 01; 314(13):2352-61. PubMed ID: 18602100 [Abstract] [Full Text] [Related]
6. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Morris MC, Depollier J, Mery J, Heitz F, Divita G. Nat Biotechnol; 2001 Dec 01; 19(12):1173-6. PubMed ID: 11731788 [Abstract] [Full Text] [Related]
7. Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide. Sugita T, Yoshikawa T, Mukai Y, Yamanada N, Imai S, Nagano K, Yoshida Y, Shibata H, Yoshioka Y, Nakagawa S, Kamada H, Tsunoda S, Tsutsumi Y. Biochem Biophys Res Commun; 2007 Nov 30; 363(4):1027-32. PubMed ID: 17923117 [Abstract] [Full Text] [Related]
8. Tuning the transport properties of HIV-1 Tat arginine-rich motif in living cells. Cardarelli F, Serresi M, Bizzarri R, Beltram F. Traffic; 2008 Apr 30; 9(4):528-39. PubMed ID: 18182009 [Abstract] [Full Text] [Related]
9. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Tkachenko AG, Xie H, Liu Y, Coleman D, Ryan J, Glomm WR, Shipton MK, Franzen S, Feldheim DL. Bioconjug Chem; 2004 Apr 30; 15(3):482-90. PubMed ID: 15149175 [Abstract] [Full Text] [Related]
10. [Construction and functional study of a cell penetrating peptide-based expression vector for targeted delivery of proteins into the cell nuclei]. Li HY, Guo AH, Liu ZF, Liu Y, Liu JH, Deng P, Li ZJ, Liu YW, Jiang Y. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct 30; 26(10):1394-9, 1407. PubMed ID: 17062334 [Abstract] [Full Text] [Related]
11. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Wadia JS, Dowdy SF. Adv Drug Deliv Rev; 2005 Feb 28; 57(4):579-96. PubMed ID: 15722165 [Abstract] [Full Text] [Related]
12. Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein. Friedler A, Zakai N, Karni O, Friedler D, Gilon C, Loyter A. J Mol Biol; 1999 Jun 11; 289(3):431-7. PubMed ID: 10356319 [Abstract] [Full Text] [Related]
13. A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is pro-apoptogenic. Baker RD, Howl J, Nicholl ID. Peptides; 2007 Apr 11; 28(4):731-40. PubMed ID: 17287047 [Abstract] [Full Text] [Related]
14. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery. Rajagopalan R, Xavier J, Rangaraj N, Rao NM, Gopal V. J Gene Med; 2007 Apr 11; 9(4):275-86. PubMed ID: 17397090 [Abstract] [Full Text] [Related]
15. Intracellular cargo delivery using tat peptide and derivatives. Zhao M, Weissleder R. Med Res Rev; 2004 Jan 11; 24(1):1-12. PubMed ID: 14595670 [Abstract] [Full Text] [Related]
16. Enhanced nuclear import and transfection efficiency of TAT peptide-based gene delivery systems modified by additional nuclear localization signals. Yi WJ, Yang J, Li C, Wang HY, Liu CW, Tao L, Cheng SX, Zhuo RX, Zhang XZ. Bioconjug Chem; 2012 Jan 18; 23(1):125-34. PubMed ID: 22148643 [Abstract] [Full Text] [Related]
17. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos. Chugh A, Eudes F. FEBS J; 2008 May 18; 275(10):2403-14. PubMed ID: 18397318 [Abstract] [Full Text] [Related]
18. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. Snyder EL, Dowdy SF. Curr Opin Mol Ther; 2001 Apr 18; 3(2):147-52. PubMed ID: 11338927 [Abstract] [Full Text] [Related]
19. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain. Sangadala S, Okada M, Liu Y, Viggeswarapu M, Titus L, Boden SD. Protein Expr Purif; 2009 Jun 18; 65(2):165-73. PubMed ID: 19284982 [Abstract] [Full Text] [Related]
20. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides. Hodoniczky J, Sims CG, Best WM, Bentel JM, Wilce JA. Biopolymers; 2008 Jun 18; 90(5):595-603. PubMed ID: 18351583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]